SLS Business Summary

Sagittarius Life Science Corp. (SLS), listed on the Taipei Exchange under ticker 3205.TWO, operates as an integrated biotechnology and consumer health enterprise specializing in the research, development, and commercialization of Chinese and Western medicines, functional health foods, and organic products. The company generates revenue through a diversified multi-channel model encompassing product sales, technical consulting, and licensing of its proprietary biotechnological formulations. Its primary business segments include Health Food and Supplements, which focus on probiotic fermentation and nutritional additives; Pharmaceutical R&D, targeting plant-derived and traditional herbal medicines; and a Consumer Goods division that distributes organic foods, pet supplies, and functional beverages across Taiwan and broader Asian markets. Within the competitive landscape, SLS contends with major local peers such as Grape King Bio Ltd (1707), Microbio Co Ltd (4128), and NatureWise Biotech & Medicals (4732), positioning itself as a mid-cap specialist that bridges traditional medicinal practices with modern clinical biotechnology. The leadership team at SLS is currently headed by Chairman Yang Qing-Zong, who assumed the role following a significant board reorganization in late 2025 and brings extensive experience from his previous executive tenures at Xin Nong Technology and Fei Cheng Enterprise. As of January 1, 2026, Yang Chao-Wei serves as the General Manager (CEO), succeeding Chen Jun-Heng; Yang holds a background in computer science from the University of Illinois Urbana-Champaign and previously led operations at Xin Nong Technology. The executive suite is further supported by Vice Chairman Shi Guo-Fen and Vice President Wu Di-Miao, who also serves as the company’s primary spokesperson. The board is rounded out by a mix of industry veterans and independent directors, including Chen Rong-Chao and Lai Shu-He, ensuring a governance structure focused on clinical validation and regional market expansion.